VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 46 filers reported holding VERRICA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $443 | -99.3% | 114 | -98.4% | 0.00% | – |
| Q1 2022 | $60,000 | -20.0% | 7,323 | -10.3% | 0.00% | – |
| Q4 2021 | $75,000 | -22.7% | 8,161 | +5.4% | 0.00% | – |
| Q3 2021 | $97,000 | +6.6% | 7,741 | -3.9% | 0.00% | – |
| Q2 2021 | $91,000 | -27.8% | 8,058 | -3.0% | 0.00% | – |
| Q1 2021 | $126,000 | +21.2% | 8,310 | -8.3% | 0.00% | – |
| Q4 2020 | $104,000 | +103.9% | 9,063 | +38.5% | 0.00% | – |
| Q3 2020 | $51,000 | -21.5% | 6,546 | +10.2% | 0.00% | – |
| Q2 2020 | $65,000 | +41.3% | 5,942 | +41.8% | 0.00% | – |
| Q1 2020 | $46,000 | -33.3% | 4,191 | -5.8% | 0.00% | – |
| Q4 2019 | $69,000 | +35.3% | 4,449 | +24.9% | 0.00% | – |
| Q3 2019 | $51,000 | -55.3% | 3,563 | -64.0% | 0.00% | – |
| Q2 2019 | $114,000 | -20.8% | 9,901 | -26.5% | 0.00% | – |
| Q1 2019 | $144,000 | +136.1% | 13,462 | +77.6% | 0.00% | – |
| Q4 2018 | $61,000 | -84.8% | 7,582 | -69.5% | 0.00% | – |
| Q3 2018 | $402,000 | – | 24,820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 108,794 | $1,252,000 | 0.47% |
| Perceptive Advisors | 3,410,412 | $39,254,000 | 0.42% |
| KNOTT DAVID M | 76,585 | $881,000 | 0.40% |
| Fosun International Ltd | 324,061 | $3,730,000 | 0.24% |
| Orbimed Advisors | 1,479,733 | $17,032,000 | 0.15% |
| SteelPeak Wealth, LLC | 132,961 | $1,530,000 | 0.14% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 665,511 | $7,660,000 | 0.13% |
| Capital Investment Advisory Services, LLC | 15,125 | $174,000 | 0.03% |
| BECK MACK & OLIVER LLC | 10,000 | $115,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 335,318 | $3,860,000 | 0.00% |